newsfilter
← Latest News
PR Newswire·

Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference

PALO ALTO, Calif., Sept. 5, 2023 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases,